For PD-L1, a tumour proportion scoring (TPS) threshold of 1% was used for all tumour types, except BC, wherein a combined positive score (CPS) threshold of 10 was used, and NSCLC, wherein a TPS threshold of 50% was used. This evidence concerns the gene CD274 and neoplasm.